Archived Seminar: Parkinson's Disease and Why Development Matters
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
Archived Seminar: Parkinson's Disease and Why Development Matters
Date: Sept. 25, 2020
Time: 11:00 a.m. - 12:00 p.m.
Parkinson’s Disease (PD) is defined clinically by motor symptoms that usually arise late in life and are the result of the loss of dopaminergic neurons, but a variety of nonmotor symptom including depression can precede these symptoms by many years, and genes causing PD are normally expressed throughout the lifespan, including development. It is with this in mind, that we have been examining the effect of PD-causing gene mutations on brain development. Our data show that a knockin mutation of the most prevalent genetic cause of PD, LRRK2-G2019S, alters the structure and function of corticostriatal circuits, and suggest that LRRK2-G2019S coopts synaptic circuits early in life, biasing the actions of cellular pathways in ways that have enduring consequences for learning and stress-related responses in young adulthood. The changes we observe serve to outline novel pathways that can be used to understand, detect, or treat PD.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Neurobiology Research and the Center for Glial Biology in Health, Disease, and Cancer. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
-
Home ItemBiobehavioral Susceptibility for Obesity: Behavioral, Genetic and Neuroimaging Studies of Appetite , home
Sept. 6, 2024, 11:00 a.m. | Susan Carnell, Ph.D., Associate Professor, Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine | Co-Sponsored by the Center for Health Behaviors Research and the Addiction Recovery Research Center, Fralin Biomedical Research Institute
-
Home ItemDevelopment of Genome Editor Therapies for Angelman Syndrome , home
Sept. 13, 2024, 11:00 a.m. | Mark J. Zylka, Ph.D., W.R. Kenan, Jr. Distinguished Professor, University of North Carolina at Chapel Hill; Director, UNC Neuroscience Center | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home ItemUnderstanding the Limits of Exercise Responsiveness in Older Adults , home
Sept. 20, 2024, 11:00 a.m. | Ian R. Lanza, Ph.D., Professor of Medicine, Mayo Clinic College of Medicine and Science | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute
-
Home ItemFrom Variant Functionality to Resistance in Cancer , home
Sept. 27, 2024, 11:00 a.m. | Tiki Hayes, Ph.D., Assistant Professor, Department of Molecular and Medical Pharmacology, UCLA David Geffen School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.
-
Home ItemDisrupting Health Care Using Deep Data and Remote Monitoring , home
Oct. 4, 2024, 11:00 a.m. | Michael Snyder, Ph.D., Professor, Genetics, Director, Center for Genomics and Personalized Medicine, Stanford Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
Deanna Benson, Ph.D.
Professor in the Nash Family Department of Neuroscience and the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai